SECTOR GAMMA AS
CIK 1475373 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $461.0M
- Posisi
- 40
- Per tanggal
- 30 Juni 2026
#3.995 dari 9.443 berdasarkan nilai 13F · top 42.3%
Nilai portofolio QoQ: +8.9% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 48,35%
- Bobot 25 kepemilikan teratas
- 84,48%
- Posisi di atas 1%
- 32
- Jumlah posisi efektif
- 27,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 20,17% Perkiraan pembelian $100.250.104 · penjualan $89.211.477
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 60,6% masih dipegang
- Posisi baru
- 7
- Meningkat
- 19
- Menurun
- 11
- Tertutup
- 9
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +14.8% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 98,9% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
98,8%
Lainnya/Tidak terpetakan
1,2%
Portofolio lengkap 40 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company Common Stock | $41.838.746 | 9,08% | 726.115 | $-8.373.450 | Turun ×1 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $27.885.528 | 6,05% | 217.008 | $-3.430.771 | Turun ×2 | ||
| MDT Medtronic plc. Ordinary Shares | $27.571.147 | 5,98% | 352.437 | $3.250.052 | Naik ×2 | ||
| PFE Pfizer, Inc. Common Stock | $24.181.497 | 5,25% | 1.004.215 | $-6.464.594 | Turun ×1 | ||
| INCY Incyte Corporation - Common Stock | $19.356.560 | 4,20% | 170.753 | $484.559 | Turun ×2 | ||
| ELV Elevance Health, Inc. Common Stock | $17.209.098 | 3,73% | 44.499 | $4.339.222 | Naik ×3 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $16.875.208 | 3,66% | 294.918 | $3.322.240 | Naik ×4 | ||
| TMO Thermo Fisher Scientific Inc Common Stock | $16.837.674 | 3,65% | 33.584 | ||||
| CVS CVS Health Corporation Common Stock | $16.069.613 | 3,49% | 155.337 | $6.349.710 | Naik ×1 | ||
| IQV IQVIA Holdings, Inc. Common Stock | $15.060.340 | 3,27% | 77.944 | $8.199.516 | Naik ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $15.022.918 | 3,26% | 189.468 | $2.297.566 | Naik ×1 | ||
| BDX Becton, Dickinson and Company Common Stock | $14.099.113 | 3,06% | 93.168 | $1.109.557 | Naik ×1 | ||
| ABT Abbott Laboratories Common Stock | $13.379.069 | 2,90% | 147.444 | $4.392.159 | Naik ×1 | ||
| GEHC GE HealthCare Technologies Inc. - Common Stock | $13.305.311 | 2,89% | 207.863 | $4.306.878 | Naik ×6 | ||
| ZBH Zimmer Biomet Holdings, Inc. Common Stock | $12.251.210 | 2,66% | 142.307 | $-1.839.391 | Turun ×1 | ||
| BIIB Biogen Inc. - Common Stock | $11.702.458 | 2,54% | 54.163 | $-4.814.842 | Turun ×1 | ||
| QGEN Qiagen N.V. Common Shares | $11.246.724 | 2,44% | 287.640 | $4.745.389 | Naik ×1 | ||
| CNC Centene Corporation Common Stock | $10.424.777 | 2,26% | 162.405 | $5.107.637 | |||
| REGN Regeneron Pharmaceuticals, Inc. - Common Stock | $9.839.461 | 2,13% | 15.780 | ||||
| BIO Bio-Rad Laboratories, Inc. Class A Common Stock | $9.791.894 | 2,12% | 33.350 | $3.171.581 | Naik ×1 | ||
| CAH Cardinal Health, Inc. Common Stock | $9.666.079 | 2,10% | 40.689 | $-1.934.206 | Turun ×2 | ||
| AMGN Amgen Inc. - Common Stock | $9.516.876 | 2,06% | 26.281 | $-7.074.611 | Turun ×3 | ||
| BRKR Bruker Corporation - Common Stock | $9.168.543 | 1,99% | 152.352 | $-6.298 | Turun ×2 | ||
| AVTR Avantor, Inc. Common Stock | $8.970.271 | 1,95% | 906.088 | $3.518.311 | Naik ×1 | ||
| PTCT PTC Therapeutics, Inc. - Common Stock | $8.157.000 | 1,77% | 100.000 | $3.047.250 | Naik ×2 | ||
| LH Labcorp Holdings Inc. Common Stock | $7.285.320 | 1,58% | 26.019 | $2.210.861 | Naik ×1 | ||
| DXCM DexCom, Inc. - Common Stock | $6.877.917 | 1,49% | 102.122 | $3.353.455 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $5.682.470 | 1,23% | 21.305 | Naik ×1 | |||
| EW Edwards Lifesciences Corporation Common Stock | $5.463.965 | 1,19% | 60.402 | $626.973 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $5.284.415 | 1,15% | 241.739 | $-1.396.709 | Turun ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $5.169.743 | 1,12% | 121.128 | Naik ×1 | |||
| KURA Kura Oncology, Inc. - Common Stock | $4.750.142 | 1,03% | 433.012 | $1.402.127 | Naik ×1 | ||
| TVTX Travere Therapeutics, Inc. - Common Stock | $4.544.800 | 0,99% | 80.000 | Naik ×1 | |||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $4.289.380 | 0,93% | 114.628 | $868.218 | Naik ×1 | ||
| TNDM Tandem Diabetes Care, Inc. - Common Stock | $4.030.403 | 0,87% | 267.091 | $-1.089.731 | |||
| IOVA Iovance Biotherapeutics, Inc. - Common Stock | $4.028.819 | 0,87% | 968.466 | $869.819 | Naik ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $3.833.550 | 0,83% | 45.000 | Naik ×1 | |||
| OGN Organon & Co. Common Stock | $3.666.375 | 0,80% | 270.781 | $1.414.291 | Turun ×1 | ||
| ARDX Ardelyx, Inc. - Common Stock | $3.502.904 | 0,76% | 686.844 | $411.279 | Naik ×1 | ||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $3.133.195 | 0,68% | 185.177 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| BMY | Dipangkas | -102K | -$8.4M |
| IQV | Beli lebih banyak | +38K | +$8.2M |
| AMGN | Dipangkas | -21K | -$7.1M |
| PFE | Dipangkas | -87K | -$6.5M |
| CVS | Beli lebih banyak | +20K | +$6.3M |
| CNC | Hanya pergerakan harga | +0 | +$5.1M |
| BIIB | Dipangkas | -36K | -$4.8M |
| QGEN | Beli lebih banyak | +125K | +$4.7M |
| ABT | Beli lebih banyak | +60K | +$4.4M |
| ELV | Beli lebih banyak | +537 | +$4.3M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| JNJ | 30 Juni 2025 | 98.000 | $16.252.320 | 78,0% |
| TMO | 31 Maret 2026 | 21.688 | $12.567.112 | 26,1% |
| UNH | 30 Juni 2026 | 36.435 | $9.858.947 | -5,6% |
| BAX | 31 Des. 2025 | 381.551 | $8.687.916 | 39,3% |
| GILD | 30 Juni 2026 | 53.247 | $7.421.034 | 15,1% |
| LNTH | 30 Juni 2026 | 93.344 | $7.080.142 | -9,5% |
| VTRS | 31 Des. 2025 | 668.851 | $6.621.625 | 30,0% |
| HUM | 31 Des. 2025 | 23.942 | $6.228.990 | 49,4% |
| ELAN | 31 Des. 2025 | 307.271 | $6.188.438 | 7,0% |
| QGENXXXX | 30 Sep. 2025 | 117.000 | $5.623.020 | Tidak lagi dilacak |
| REGN | 31 Maret 2026 | 7.165 | $5.530.449 | 8,1% |
| HCA | 31 Maret 2026 | 10.784 | $5.034.618 | -13,3% |
| ASND | 30 Juni 2026 | 21.305 | $4.873.093 | -2,8% |
| ICLR | 31 Des. 2025 | 24.967 | $4.369.225 | -2,9% |
| SOLV | 31 Des. 2025 | 59.259 | $4.325.907 | 11,6% |
| HUM | 30 Juni 2026 | 19.202 | $3.329.435 | -3,6% |
| BBIO | 30 Juni 2026 | 44.263 | $3.286.970 | 11,8% |
| DNLI | 30 Juni 2026 | 162.710 | $3.124.032 | -2,3% |
| COGT | 30 Juni 2026 | 80.000 | $3.079.200 | -6,3% |
| TGTX | 30 Sep. 2025 | 82.000 | $2.951.180 | 45,1% |
| BNTX | 31 Des. 2025 | 27.732 | $2.734.930 | 13,9% |
| ACLX | 31 Des. 2025 | 32.009 | $2.627.939 | Tidak lagi dilacak |
| THC | 30 Sep. 2025 | 12.500 | $2.200.000 | 35,0% |
| CGON | 31 Maret 2026 | 52.039 | $2.160.659 | 16,6% |
| CERT | 31 Maret 2026 | 230.565 | $2.031.278 | 49,9% |
| ARWR | 30 Juni 2026 | 30.000 | $1.881.000 | 7,1% |
| LEGN | 31 Maret 2025 | 48.495 | $1.578.027 | -33,9% |